Doximity, Inc. $DOCS Shares Purchased by Wellington Management Group LLP

Wellington Management Group LLP boosted its position in shares of Doximity, Inc. (NYSE:DOCS) by 24.7% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,135,113 shares of the company’s stock after acquiring an additional 621,464 shares during the quarter. Wellington Management Group LLP’s holdings in Doximity were worth $65,022,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Doximity by 0.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company’s stock valued at $2,262,000 after purchasing an additional 210 shares during the period. BOKF NA increased its stake in Doximity by 5.3% during the 3rd quarter. BOKF NA now owns 5,356 shares of the company’s stock worth $392,000 after buying an additional 269 shares during the period. Northwestern Mutual Investment Management Company LLC increased its stake in Doximity by 1.1% during the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 30,736 shares of the company’s stock worth $1,361,000 after buying an additional 333 shares during the period. Lifestyle Asset Management Inc. lifted its holdings in Doximity by 5.9% during the 4th quarter. Lifestyle Asset Management Inc. now owns 7,083 shares of the company’s stock worth $314,000 after buying an additional 396 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. lifted its holdings in Doximity by 99.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 796 shares of the company’s stock worth $35,000 after buying an additional 397 shares in the last quarter. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Doximity Price Performance

NYSE DOCS opened at $26.33 on Thursday. Doximity, Inc. has a 1 year low of $17.15 and a 1 year high of $76.51. The company has a market capitalization of $4.69 billion, a PE ratio of 30.97, a P/E/G ratio of 20.61 and a beta of 1.25. The company has a fifty day moving average of $23.06 and a two-hundred day moving average of $23.06.

Doximity (NYSE:DOCS) last posted its earnings results on Thursday, August 6th. The company reported $0.29 EPS for the quarter, topping analysts’ consensus estimates of $0.16 by $0.13. Doximity had a return on equity of 18.06% and a net margin of 25.48%.The business had revenue of $156.62 million for the quarter. During the same quarter last year, the firm posted $0.36 EPS. The firm’s revenue for the quarter was up 7.3% on a year-over-year basis. On average, research analysts expect that Doximity, Inc. will post 0.74 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts have commented on DOCS shares. Barclays boosted their price target on shares of Doximity from $20.00 to $27.00 and gave the stock an “equal weight” rating in a research note on Friday, August 21st. Wolfe Research upgraded Doximity to an “outperform” rating in a report on Thursday, August 13th. Jefferies Financial Group cut Doximity from a “buy” rating to a “hold” rating and lowered their target price for the stock from $51.00 to $19.00 in a research note on Thursday, May 14th. JPMorgan Chase & Co. upped their price target on Doximity from $26.00 to $31.00 and gave the stock a “neutral” rating in a report on Friday, August 7th. Finally, The Goldman Sachs Group decreased their price objective on Doximity from $28.00 to $24.00 and set a “neutral” rating for the company in a research note on Thursday, May 14th. Two research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, twelve have issued a Hold rating and four have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $32.43.

Insiders Place Their Bets

In other Doximity news, Director Timothy S. Cabral sold 7,500 shares of the business’s stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $39.11, for a total value of $293,325.00. Following the completion of the sale, the director owned 3,221 shares in the company, valued at approximately $125,973.31. The trade was a 69.96% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Kira Scherer Wampler sold 2,000 shares of the stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $24.95, for a total value of $49,900.00. Following the completion of the sale, the director directly owned 19,839 shares of the company’s stock, valued at $494,983.05. The trade was a 9.16% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 13,714 shares of company stock valued at $437,251 over the last quarter. Company insiders own 31.80% of the company’s stock.

About Doximity

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.